Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.8200 (-4.9%) ($5.7500 - $6.0800) on Fri. Jan. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.64% (three month average) | RSI | 57 | Latest Price | $5.8200(-4.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.8% a day on average for past five trading days. | Weekly Trend | CGEN advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(66%) ARKK(63%) XBI(63%) IBB(57%) IBUY(55%) | Factors Impacting CGEN price | CGEN will decline at least -1.82% in a week (0% probabilities). VXX(-37%) VIXM(-33%) UUP(-11%) TLT(-4%) SHY(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.82% (StdDev 3.64%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
5 Day Moving Average | $5.99(-2.84%) | 10 Day Moving Average | $5.89(-1.19%) | 20 Day Moving Average | $5.77(0.87%) | To recent high | -5.5% | To recent low | 16.2% | Market Cap | $481m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |